Market Access
Europe’s new HTA reality: The JCA, one year on
Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.
News
TransThera's resistant biliary cancer drug cleared in China
TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
News
Third time lucky for Replimune as FDA OKs melanoma drug
At its third attempt, Replimune has finally won FDA approval for its advanced melanoma treatment RP1, now named Tudriqev and its first product.
News
Novo Nordisk wins Netherlands GLP-1 compounding lawsuit
A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide.
News
Takeda's first-in-class narcolepsy drug claims FDA approval
Takeda's orexin agonist Orzeyful is the first drug approved in the US that can treat the "full range" of narcolepsy type 1 symptoms, says the FDA.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
